HIV-positive children more likely to develop drug resistance

May 28, 2014 by Keith Brannon, Tulane University
The study emphasizes the importance of drug adherence for children and adolescents with HIV, says Dr. Russell Van Dyke. Credit: Paula Burch-Celentano

Children born with HIV are far more likely to develop resistance to antiretroviral drugs than adults, according to a new Tulane University School of Medicine study.

Researchers following almost 450 children enrolled in the Pediatric HIV/AIDS Cohort Study, one of the largest studies of HIV-positive children in the United States, found that 74 percent had developed resistance to at least one form of drug treatment and 30 percent were resistant to at least two classes of HIV treatment drugs. In comparison, nearly 36 percent of adults with HIV have resistance to one form of and only 12 percent have resistance to at least two classes.

The study, which tracks patients at 14 sites across the country, followed participants from 7 to 16 years of age at enrollment.

"The problem with is that once you develop it, it never goes away," said principal investigator Dr. Russell Van Dyke, professor of pediatric infectious diseases. "Some patients with very resistant virus have no effective treatment options. Resistant virus is the major reason for death among youth with perinatal HIV."

Fortunately, most adolescents with resistant HIV remain sensitive to newer agents from all classes, allowing salvage therapy. Just one child in the study had resistance to all HIV drugs and only 18 percent had resistance to one drug from each of the three primary classes of HIV medications.

The study emphasizes the importance of drug adherence for children and adolescents with HIV who typically take multiple medications daily to manage the disease. Once daily, single-pill HIV medications for adults are not yet available for children, Van Dyke said.

"The best way to prevent resistance from developing is to take your medicine and suppress your viral load," Van Dyke said. "You develop resistance when you take some of your medications but not all. Then you've got virus that is replicating in the face of taking your medication. Lack of adherence is the major reason develops."

The study abstract was presented recently at the Conference on Retroviruses and Opportunistic Infections.

Explore further: Soy sauce molecule may unlock drug therapy for HIV patients

More information: The abstract is available online: croiconference.org/sites/all/abstracts/897.pdf

Related Stories

Soy sauce molecule may unlock drug therapy for HIV patients

May 5, 2014
For HIV patients being treated with anti-AIDS medications, resistance to drug therapy regimens is commonplace. Often, patients develop resistance to first-line drug therapies, such as Tenofovir, and are forced to adopt more ...

The evolution of drug resistance within a HIV population

January 23, 2014
Drug resistance mutations in HIV reduce the genetic diversity in the rest of the virus genome when they spread within an infected patient, but they do so to a different extent in different patients. A new study published ...

Dolutegravir in HIV-1 infection: Added benefit in adult patients

May 21, 2014
Dolutegravir has been approved since January 2014 in combination with other antiretroviral drugs for the treatment of human immunodeficiency virus (HIV) infected adults and adolescents above 12 years of age. In an early benefit ...

Kids born with HIV growing up well

April 21, 2011
(PhysOrg.com) -- Once facing an almost certain death sentence, most children born with HIV are now faring well into adolescence and adulthood, according to a newly published study co-authored by Tulane infectious diseases ...

Mississippi child points HIV researchers in new direction

April 25, 2013
(Medical Xpress)—Earlier this year, doctors at an infectious disease conference announced that a baby in rural Mississippi born with HIV had been "functionally cured" of the infection after receiving aggressive treatment ...

Recommended for you

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

Researchers find clues to AIDS resistance in sooty mangabey genome

January 3, 2018
Peaceful co-existence, rather than war: that's how sooty mangabeys, a monkey species found in West Africa, handle infection by SIV, a relative of HIV, and avoid developing AIDS-like disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.